Health and Fitness

NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine

Most read stories this week

Take a Survey

ARCHIVES